• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thrombosis (2100); Injury (2348)
Event Date 08/24/2018
Event Type  Injury  
Manufacturer Narrative
Patient identifier: (b)(6).Date of birth: (b)(6).Device is a combination product.
 
Event Description
(b)(6) clinical study.It was reported that stent thrombosis occurred resulting in hospitalization and amputation.The patient underwent treatment with two 6x120 study stents on (b)(6) 2018.The target lesion, located in the right mid superficial femoral artery with a 5.8 mm and 5.9 mm reference vessel diameter.The lesion's length was 80mm proximally and distally respectively.The lesion was 100% stenosed and was crossed through the true lumen.Pre-dilatation was performed using 5 balloons; subsequently the study stents were implanted.Post-dilatation was not performed; there was 10% residual stenosis.No thrombus was seen in the treated vessel at the end of the procedure.On (b)(6) 2018, the patient was hospitalized to undergo major amputation due to stent thrombosis.The patient was discharged on (b)(6) 2018 and the event was assessed as resolved with sequelae as of the same day.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key9311168
MDR Text Key166050220
Report Number2134265-2019-13719
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Physician
Type of Report Initial
Report Date 11/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/12/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/05/2018
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0020890480
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/06/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/08/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
STENT: 6X120MM ELUVIA STENT
Patient Outcome(s) Hospitalization; Disability;
Patient Age81 YR
-
-